“Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study: Ceftolozane-Tazobatam for febrile neutropenia”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020065, Aug. 2020, doi: 10.4084/mjhid.2020.065.